Compare MKS Instruments (MKSI) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MKS Instruments vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? MKS Instruments trades at $265.61 (market cap $17.61B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.88 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is the larger of the two by market cap, and Royalty Pharma plc Class A Ordinary Shares pays the higher dividend (1.66%). Which is the better fit depends on your goals — on Pluang, investors hold MKS Instruments for 7 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| MKSI | RPRX | |
|---|---|---|
Market Cap | $17.61B | $25.27B |
Volume | 1,275,355 | 3,671,183 |
Sector | Technology | Health |
52-Week High | $444.80 | $63.96 |
52-Week Low | $121.26 | $35.44 |
Typical Hold Time | 7 Days | 1 Days |
Enterprise Value | $21.18B | $32.50B |
Dividend Yield | 0.38% | 1.66% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MKS Instruments
MKS develops instruments, systems, and process control solutions for advanced manufacturing. Its technologies serve semiconductor manufacturing, electronics and packaging, photonics, and specialty industrial applications.
Read more on MKSI →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
